Skip to main content
News Archive

Already missing FDA’s vocal commish? Scott Gottlieb will keep chiming in on drug pricing in new role – Endpoints News

By April 8, 2019May 22nd, 2025No Comments

NewImage

As head of the FDA, Scott Gottlieb has been outspoken about drug pricing, chiming in on an area that is typically tangential to the agency commissioner’s purview. In the first announcement of his next steps — made one day before he’s scheduled to officially end his shorter-than-expected tenure — Gottlieb says he’s returning to the American Enterprise Institute as a resident fellow focused on these exact issues.

{iframe}https://endpts.com/already-missing-fdas-vocal-commish-he-will-keep-chiming-in-on-drug-pricing-in-new-role/{/iframe}

Search

You have successfully subscribed to the newsletter

There was an error while trying to send your request. Please try again.

BioHealth Innovation will use the information you provide on this form to be in touch with you and to provide updates and marketing.